arrow
M

Marta Larráyoz

clínica universidad de navarra
H指数:24
被引数:1,754

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response

MGUS进展为骨髓瘤以及治疗后反应期间基质和内皮的转录变化

2026-06-230
OAAI
Characterization of the bone marrow architecture of multiple myeloma using spatial transcriptomics

利用空间转录组学对多发性骨髓瘤骨髓结构进行表征

2025-11-200
OAAI
Reprogramming glutamine metabolism enhances BCMA-CART cell fitness and therapeutic efficacy in multiple myeloma

重编程谷氨酰胺代谢增强了BCMA-CART细胞的适应性和在多发性骨髓瘤中的治疗效能。

Blood
IF23.1
2025-09-220
OAAI
Phosphatidylserine as a tumor target for CAR-T cell therapy

磷脂酰丝氨酸作为CAR-T细胞疗法的肿瘤靶点

2025-02-230
OA
Mapping Disease Transitions from Premalignant, Asymptomatic to Advanced Myeloma through Integrative Epigenomic and Transcriptional Analyses

通过整合表观基因组学和转录组学分析,映射从癌前、无症状到晚期骨髓瘤的疾病转变。

BLOOD
IF23.1
2024-11-050
PRE
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
2023-09-206
OAAI
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

用于预测遗传异质性多发性骨髓瘤的免疫治疗结果和免疫逃避机制的临床前模型

2023-03-1628
OAAI
Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma
2022-01-317
OAAI
Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma
2022-01-2123
OAAI
Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death
2020-12-1847
OA
Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial
LEUKEMIA
IF13.4
2020-02-0337
OAAI
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials
2019-08-2125
OAAI
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia
2018-09-2740
OAAI
The clinical importance of DNA methylation signatures in chronic lymphocytic leukemia patients treated with chemo-immunotherapy
2018-07-010
PRE
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia
2018-03-3024
PREAI
The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia
2017-04-3054
OAAI
Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
LEUKEMIA
IF13.4
2016-05-2065
OAAI